Aarey Drugs & Pharmaceuticals Ltd. - Research Center
524412 AREYDRG Group (B) BSE data
Add to watchlist
| Results |
Quarterly
|
| Statement | |
| More |
Quarterly results in brief
(Rs crore)
| Sep' 21 | Jun' 21 | Mar' 21 | Jun' 20 | Mar' 20 | |
|---|---|---|---|---|---|
| Sales | 134.65 | 97.52 | 178.25 | 25.22 | 110.68 |
| Operating profit | 3.42 | 2.93 | 2.36 | 1.74 | -0.49 |
| Interest | 0.61 | 0.47 | 0.56 | 0.47 | 0.37 |
| Gross profit | 3.62 | 3.13 | 3.44 | 2.01 | 2.56 |
| EPS (Rs) | 1.22 | 1.07 | 0.60 | 0.62 | 0.43 |
Quarterly
results in details
| Sep' 21 | Jun' 21 | Mar' 21 | Jun' 20 | Mar' 20 | |
|---|---|---|---|---|---|
| Other income | 0.81 | 0.67 | 1.64 | 0.74 | 3.42 |
| Stock adjustment | -4.96 | 8.38 | 11.53 | - | - |
| Raw material | 134.28 | 84.53 | 163.49 | 21.59 | 109.77 |
| Power and fuel | - | - | - | - | - |
| Employee expenses | 0.13 | 0.11 | 0.40 | - | - |
| Excise | - | - | - | - | - |
| Admin and selling expenses | - | - | - | - | - |
| Research and development expenses | - | - | - | - | - |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 1.78 | 1.58 | 0.48 | 1.89 | 1.40 |
| Provisions made | - | - | - | - | - |
| Depreciation | 0.50 | 0.40 | 0.25 | 0.37 | 0.11 |
| Taxation | 0.28 | 0.22 | 1.79 | 0.20 | 1.45 |
| Net profit / loss | 2.84 | 2.51 | 1.41 | 1.44 | 1.00 |
| Extra ordinary item | - | - | - | - | - |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 23.38 | 23.38 | 23.38 | 23.38 | 23.38 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | - | - | - | - | - |
| Agg.of non promotoholding (%) | - | - | - | - | - |
| OPM (%) | 2.54 | 3.00 | 1.32 | 6.91 | -0.44 |
| GPM (%) | 2.68 | 3.19 | 1.91 | 7.76 | 2.24 |
| NPM (%) | 2.10 | 2.55 | 0.78 | 5.55 | 0.87 |
© 2022 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis